title: N-hydroxyethyl-4-aza-didehydropodophyllotoxin derivatives as potential antitumor agents.
abstract: Three different series of N-hydroxyethyl aza-podophyllotoxin derivatives containing (i) a five-membered methylenedioxy ring (7a-f), (ii) a five-membered ring with no heteroatom (8a-f) or (iii) a six membered ethylenedioxy ring (9a-f) as ring A were synthesized using a convenient one-pot multi-component reaction. Further variation on ring E was done by decorating it with methoxy and hydroxy groups at different positions. Calculation of logP values of these compounds indicates them to be better soluble than corresponding non-hydroxy derivatives. These novel aza-podophyllotoxin derivatives were screened for their cytostatic and cytotoxic activities on National Cancer Institute's 60 human tumor cell lines to study the structure activity relationship. The overall anticancer activity of these compounds was in the order of 8a-f>9a-f>7a-f. Furthermore, the compounds having 3'-methoxy and 3',4',5'-trimethoxy substitution at ring E were the most active within the series. The cytotoxicity of all the active compounds was low, while their antiproliferative (or cytostatic) activity was high, providing a wide therapeutic window for their potential application as anticancer drugs.
authors: Department of Chemistry, University of Puerto Rico at Humacao, PR 00791, USA.
authors: Ajay
authors: A
authors: Kumar
authors: Vineet
authors: V
authors: Kumar
authors: Antonio E
authors: AE
authors: Alegria
authors: Sanjay V
authors: SV
authors: Malhotra
references: J Med Chem. 2004 Oct 7;47(21):5140-8
references: 15456257
references: J Med Chem. 2001 Apr 26;44(9):1422-8
references: 11311065
references: J Med Chem. 2005 Jan 27;48(2):593-603
references: 15658872
references: J Med Chem. 1992 Mar 6;35(5):866-71
references: 1312600
references: J Med Chem. 2004 Apr 22;47(9):2365-74
references: 15084135
references: Bioorg Med Chem Lett. 2000 Feb 21;10(4):315-7
references: 10714489
references: J Heterocycl Chem. 2010 Nov;47(6):1275-1282
references: 21197118
references: J Nat Prod. 2003 Jul;66(7):1022-37
references: 12880330
references: J Med Chem. 1994 Feb 18;37(4):446-52
references: 8120864
references: J Chem Inf Comput Sci. 2003 Jan-Feb;43(1):218-27
references: 12546556
references: J Med Chem. 1999 Jul 1;42(13):2441-6
references: 10395485
references: Curr Pharm Des. 2005;11(13):1695-717
references: 15892669
references: J Med Chem. 1993 Jun 11;36(12):1689-99
references: 8389875
references: J Med Chem. 1977 May;20(5):635-44
references: 853503
references: Cancer Res. 1988 Feb 1;48(3):589-601
references: 3335022
references: Nat Rev Cancer. 2006 Oct;6(10):813-23
references: 16990858
references: Org Lett. 2002 Sep 19;4(19):3187-9
references: 12227745
references: Curr Pharm Des. 2000 Dec;6(18):1811-39
references: 11102564
references: J Med Chem. 2007 Oct 18;50(21):5183-92
references: 17894480
references: Biochimie. 1998 Mar;80(3):207-22
references: 9615861
references: J Comb Chem. 2010 Jul 12;12(4):430-4
references: 20503973
references: J Med Chem. 2004 Feb 26;47(5):1214-22
references: 14971901
references: J Med Chem. 1994 Jan 21;37(2):287-92
references: 8295216
references: J Med Chem. 1992 Mar 6;35(5):871-7
references: 1312601